FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
Strong growth and pipeline momentum with three new medicines approved since the third quarter
CAMBRIDGE, United Kingdom--(BUSINESS WIRE)-- AstraZeneca:
Revenue and EPS summary
Â
Â
FY 2023
Q4 2023
Â
Â
Â
%... More

